Charles S. Berkman
2008 - Ligand Pharmaceuticals
In 2008, Charles S. Berkman earned a total compensation of $491.8K as Vice President and General Counsel at Ligand Pharmaceuticals, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $58,562 |
|---|---|
| Option Awards | $108,527 |
| Salary | $244,010 |
| Stock Awards | $78,215 |
| Other | $2,526 |
| Total | $491,840 |
Berkman received $244K in salary, accounting for 50% of the total pay in 2008.
Berkman also received $58.6K in non-equity incentive plan, $108.5K in option awards, $78.2K in stock awards and $2.5K in other compensation.
Rankings
In 2008, Charles S. Berkman's compensation ranked 6,555th out of 9,135 executives tracked by ExecPay. In other words, Berkman earned more than 28.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,555 out of 9,135 | 28th |
Division Manufacturing | 2,433 out of 3,436 | 29th |
Major group Chemicals And Allied Products | 543 out of 815 | 33rd |
Industry group Drugs | 373 out of 597 | 38th |
Industry Pharmaceutical Preparations | 277 out of 408 | 32nd |
Source: SEC filing on April 29, 2009.
Berkman's colleagues
We found four more compensation records of executives who worked with Charles S. Berkman at Ligand Pharmaceuticals in 2008.
2008
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2008
Martin Meglasson
Ligand Pharmaceuticals
Vice President, Discovery Research
2008
Zofia Dziewanowska
Ligand Pharmaceuticals
Vice President, Clinical Research and Regulatory
2008
John Sharp
Ligand Pharmaceuticals